FluidAI Medical (formerly known as NERv Technology Inc.), a Kitchener, Canada-based company leveraging artificial intelligence (AI) for postoperative patient monitoring, raised $15M in Series A funding.
The round was led by SOSV and Graphene Ventures with participation from Boutique Venture Partners, Threshold Impact, Cur8 Capital, Leva Capital, Kyto Technology & Life Science Inc., Juno Pharmaceuticals, and a number of angels, funds and government funding organizations.
The company intends to use the funds to expand into existing and new global markets, grow its team, amplify R&D efforts, and introduce novel AI-driven solutions catering to a broader range of postoperative complications.
Led by CEO Youssef Helwa, FluidAI is a medical technology company that uses AI to aid with the early detection of postoperative leaks. Its first solution, Stream™ Platform, uses advanced sensors and an AI-driven algorithm that may prompt surgeons to identify these leaks earlier, helping surgeons improve clinical outcomes.
FinSMEs
10/10/2023